Revance Therapeutics Inc (NASDAQ:RVNC)

31.19
Delayed Data
As of 3:51pm ET
 -0.41 / -1.30%
Today’s Change
14.02
Today|||52-Week Range
35.72
+84.12%
Year-to-Date
No recent news for Revance Therapeutics Inc.

Today’s Trading

Previous close31.60
Today’s open31.51
Day’s range30.25 - 31.52
Volume183,326
Average volume (3 months)226,414
Market cap$756.7M
Dividend yield--
Data as of 3:51pm ET, 07/07/2015

Growth & Valuation

Earnings growth (last year)-408.57%
Earnings growth (this year)-4.01%
Earnings growth (next 5 years)--
Revenue growth (last year)-37.93%
P/E ratioNM
Price/Sales857.68
Price/Book4.26

Competitors

 Today’s
change
Today’s
% change
DVAXDynavax Technologies...-0.52-2.04%
SCMPSucampo Pharmaceutic...+0.18+1.05%
NWBONorthwest Biotherape...+0.18+1.78%
AMPHAmphastar Pharmaceut...-0.04-0.23%
Data as of 3:51pm ET, 07/07/2015

Financials

Next reporting dateAugust 11, 2015
EPS forecast (this quarter)-$0.84
Annual revenue (last year)$383.0K
Annual profit (last year)-$62.9M
Net profit margin-16,427.42%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
L. Daniel Browne
CFO &
Executive VP-Corporate Development
Lauren P. Silvernail
Corporate headquarters
Newark, California

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers